Mabeza, Ronalyn M.
HRN: 24-15-92 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/07/2024
CO-AMOXICLAV 625MG (TAB)
01/07/2024
01/13/2024
PO
1tab
BID
Rmle
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes